Filing Details

Accession Number:
0001061983-21-000241
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-20 18:57:47
Reporting Period:
2021-10-19
Accepted Time:
2021-10-20 18:57:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1061983 Cytokinetics Inc CYTK Pharmaceutical Preparations (2834) 943291317
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1520533 A Mark Schlossberg 280 East Grand Avenue
South San Francisco CA 94080
Svp - Legal & General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-10-19 19,979 $7.03 70,829 No 4 M Direct
Common Stock Disposition 2021-10-19 19,979 $35.74 50,850 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2021-10-19 19,979 $0.00 19,979 $7.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,265 2020-01-31 2029-01-31 No 4 M Direct
Footnotes
  1. Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 30, 2021.